Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 11;24(20):15086.
doi: 10.3390/ijms242015086.

Preliminary Evidence of the Differential Expression of Human Endogenous Retroviruses in Kawasaki Disease and SARS-CoV-2-Associated Multisystem Inflammatory Syndrome in Children

Affiliations

Preliminary Evidence of the Differential Expression of Human Endogenous Retroviruses in Kawasaki Disease and SARS-CoV-2-Associated Multisystem Inflammatory Syndrome in Children

Emanuela Balestrieri et al. Int J Mol Sci. .

Abstract

Multisystem inflammatory syndrome in children (MIS-C) is a postinfectious sequela of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with some clinical features overlapping with Kawasaki disease (KD). Our research group and others have highlighted that the spike protein of SARS-CoV-2 can trigger the activation of human endogenous retroviruses (HERVs), which in turn induces inflammatory and immune reactions, suggesting HERVs as contributing factors in COVID-19 immunopathology. With the aim to identify new factors involved in the processes underlying KD and MIS-C, we analysed the transcriptional levels of HERVs, HERV-related genes, and immune mediators in children during the acute and subacute phases compared with COVID-19 paediatric patients and healthy controls. The results showed higher levels of HERV-W, HERV-K, Syn-1, and ASCT-1/2 in KD, MIS-C, and COV patients, while higher levels of Syn-2 and MFSD2A were found only in MIS-C patients. Moreover, KD and MIS-C shared the dysregulation of several inflammatory and regulatory cytokines. Interestingly, in MIS-C patients, negative correlations have been found between HERV-W and IL-10 and between Syn-2 and IL-10, while positive correlations have been found between HERV-K and IL-10. In addition, HERV-W expression positively correlated with the C-reactive protein. This pilot study supports the role of HERVs in inflammatory diseases, suggesting their interplay with the immune system in this setting. The elevated expression of Syn-2 and MFSD2A seems to be a distinctive trait of MIS-C patients, allowing to distinguish them from KD ones. The understanding of pathological mechanisms can lead to the best available treatment for these two diseases, limiting complications and serious outcomes.

Keywords: COVID-19; HERVs; Kawasaki disease; human endogenous retroviruses; inflammation; multisystem inflammatory syndrome in children.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflict of interest.

Figures

Figure 1
Figure 1
The mRNA levels of the ENV gene of HERVs, HERV-related sequences, and their putative receptors in blood samples from paediatric patients with Kawasaki disease, COVID-19, multisystem inflammatory syndrome, and healthy controls. The expression levels of (A) the env gene of HERV-W and HERV-K, (B) syncytin-1 (Syn-1), alanine/serine/cysteine/threonine-preferring transporter 1 and 2 (ASCT-1, ASCT-2), and (C) syncytin-2 (Syn-2), and the major facilitator superfamily-domain-containing 2A (MFSD2A) were analysed by qRT-PCR in blood samples from children during the acute and subacute phase of Kawasaki disease (KDa and KDsa), multisystem inflammatory syndrome (MIS-Ca and MIS-Csa), paediatric COVID-19 patients (COV) during the acute phase, and healthy controls (HCs). The results are represented as box plots depicting mild (black dot) and extreme outliers (asterisk) for each group. (D) The p-values for groupwise differences examined by the nonparametric Mann–Whitney U-test (statistical significance is defined when p < 0.050).
Figure 2
Figure 2
The mRNA levels of inflammatory and regulatory cytokines and interferon-gamma and Toll-like receptors in blood samples from paediatric patients with Kawasaki disease, COVID-19, multisystem inflammatory syndrome, and healthy controls. The mRNA levels of (A) inflammatory and regulatory cytokines: interleukin-1β (IL-1β), IL-6, and IL-10, (B) tumour necrosis factor-α (TNF-α), interferon (INF-γ), and monocyte chemoattractant protein 1 (MCP-1), and (C) Toll-like receptors (TLR-3, TLR-4, and TLR-9) were analysed by qRT-PCR in blood samples from children during the acute and subacute phase of Kawasaki disease (KDa and KDsa), multisystem inflammatory syndrome (MIS-Ca and MIS-Csa), paediatric COVID-19 patients (COV) during the acute phase, and healthy controls (HCs). The results are represented as box plots depicting mild (black dot) and extreme outliers (asterisk) for each group. (D) The p-values for groupwise differences examined by the nonparametric Mann–Whitney U-test (statistical significance is defined when p < 0.050).
Figure 3
Figure 3
Scatter plots of HERVs expression levels (X-axis) versus cytokines and CRP levels (Y-axis) in MIS-Ca and COV patients. Pairwise associations between continuous variables were tested through the Spearman correlation test. The Rho coefficients and p-values were reported.

References

    1. McCrindle B.W., Rowley A.H., Newburger J.W., Burns J.C., Bolger A.F., Gewitz M., Baker A.L., Jackson M.A., Takahashi M., Shah P.B., et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation. 2017;135:e927–e999. doi: 10.1161/CIR.0000000000000484. - DOI - PubMed
    1. Mauro A., Fabi M., Da Frè M., Guastaroba P., Corinaldesi E., Calabri G.B., Giani T., Simonini G., Rusconi F., Cimaz R. Kawasaki disease: An epidemiological study in central Italy. Pediatr. Rheumatol. Online J. 2016;14:22. doi: 10.1186/s12969-016-0084-6. - DOI - PMC - PubMed
    1. Ravelli A., Martini A. Kawasaki disease or Kawasaki syndrome? Ann. Rheum. Dis. 2020;79:993–995. doi: 10.1136/annrheumdis-2020-218110. - DOI - PMC - PubMed
    1. Rodó X., Curcoll R., Robinson M., Ballester J., Burns J.C., Cayan D.R., Lipkin W.I., Williams B.L., Couto-Rodriguez M., Nakamura Y., et al. Tropospheric winds from northeastern China carry the etiologic agent of Kawasaki disease from its source to Japan. Proc. Natl. Acad. Sci. USA. 2014;111:7952–7957. doi: 10.1073/pnas.1400380111. - DOI - PMC - PubMed
    1. Yorifuji T., Tsukahara H., Kashima S., Doi H. Intrauterine and Early Postnatal Exposure to Particulate Air Pollution and Kawasaki Disease: A Nationwide Longitudinal Survey in Japan. J. Pediatr. 2018;193:147–154.e2. doi: 10.1016/j.jpeds.2017.10.012. - DOI - PubMed

Supplementary concepts